Karla Merz, PhD, is an experienced professional in business development and research with a current position as Senior Associate for Business Development External R&D at Amgen since October 2020, focusing on strategic insights and licensing opportunities. Previously, Karla served as a Postdoctoral Researcher at City of Hope, leading projects on therapeutic targets for Type 2 Diabetes, and gained recognition as lead author on high-profile publications. Karla's educational background includes a PhD in Biology from the Irell & Manella Graduate School of Biological Sciences, a certificate in Bioscience Management from Keck Graduate Institute, and a BSc in Human/Medical Genetics from UCL.
This person is not in any teams
This person is not in any offices
Amgen
238 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.